Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236925-09-000002
Filing Date
2009-02-17
Accepted
2009-02-17 18:45:57
Documents
1
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 8169
  Complete submission text file 0001236925-09-000002.txt   10202
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address NUVELO, INC. 201 INDUSTRIAL ROAD, SUITE 310 SAN CARLOS CA 94070
Business Address 650-517-8000
BENDEKGEY E LEE (Reporting) CIK: 0001236925 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-22873 | Film No.: 09616543